Advertisement

Topics

Carl Zeiss Meditec AG Company Profile

07:09 EST 13th December 2018 | BioPortfolio

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on TecDax of the German stock exchange, is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumables. The company creates innovative visualization solutions in the field of microsurgery. The medical technology portfolio of Carl Zeiss Meditec is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy. In fiscal year 2011/12 (ended 30 September) the company's more than 2,400 employees generated revenue of just under 862 million euros.


News Articles [168 Associated News Articles listed on BioPortfolio]

New Chief Financial Officers Appointed at Carl Zeiss AG and Carl Zeiss Meditec AG

Effective 1 October 2018, Dr. Christian Müller will become Chief Financial Officer (CFO) of Carl Zeiss AG. He will succeed Thomas Spitzenpfeil who, as previously announced, will leave the company. M...

Carl Zeiss Meditec to enhance surgical ophthalmology solutions portfolio

Carl Zeiss Meditec, the ZEISS Medical Technology Segment, supplies innovative technologies and application- oriented solutions designed to help doctors enhance the quality of life of their patients. T...

Carl Zeiss Meditec buys IanTECH

Carl Zeiss Meditec AG is acquiring private ophthalmic device maker IanTECH for an undisclosed sum.

Carl Zeiss to acquire cataract surgery tech developer

Carl Zeiss Meditec has agreed to pay an undisclosed amount for Reno, Nev.-based IanTech, which makes the miLOOP device for mi -More- 

Carl Zeiss Meditec AG 2018 Q4 - Results - Earnings Call Slides

Carl Zeiss Meditec's (CZMWY) CEO Ludwin Monz on Nine Months 2018 Results - Earnings Call Transcript

Zeiss unveils next-generation Visulas green photocoagulation laser

Carl Zeiss Meditec has unveiled next-generation ophthalmic laser, Visulas green, at this year’s World Ophthalmology Congress in Barcelona, Spain.

Carl Zeiss Jena microscope part

EUR 39,00 (0 Gebote)Angebotsende: Montag Okt-15-2018 17:30:39 CESTJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Carl Zeiss Jena microscope part BioMarketplace You wan...

Drugs and Medications [0 Results]

None

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

An Evaluation of the IOLMaster 700.

To evaluate the repeatability and reproducibility of the Carl Zeiss Meditec IOLMaster 700, which uses swept-source optical coherence tomography technology, along with its agreement with the IOLMaster ...

Measurement of Posterior Corneal Astigmatism by the IOLMaster 700.

To provide the first description of posterior corneal astigmatism as measured by the IOLMaster 700 (Carl Zeiss Meditec, Jena, Germany) and assess how its characteristics compare to previous measuremen...

CIRCLE Enhancement After Myopic SMILE.

To report the outcomes of enhancement after small incision lenticule extraction (SMILE) using the VisuMax CIRCLE option (Carl Zeiss Meditec AG, Jena, Germany), which converts the SMILE cap into a femt...

Outcomes for Mixed Cylinder LASIK With the MEL 90 Excimer Laser.

To report the outcomes of LASIK for mixed cylinder using the Triple-A ablation profile with the MEL 90 excimer laser (Carl Zeiss Meditec, Jena, Germany).

Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.

We report on five patients with gadolinium-negative (non-enhancing magnetic resonance imaging-MRI) but F-fluoroethyl tyrosine positron-emission tomography (FET-PET) positive glioma (NEG) undergoing su...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser

The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or eli...

Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies

The purpose of this study is to compare the newly released Spectral OCT/SLO (OTI, Toronto, Canada) with the Zeiss Stratus OCT (Carl-Zeiss Meditec, Dublin, CA) with regards to the quality o...

Repeatability, Reproducibility and Comparison of Cirrus OCT, RTVue OCT, MS-39 OCT, and Insight 100 VHFDU

The purpose of this study is to evaluate the repeatability and reproducibility of corneal, epithelial, and LASIK flap thickness using the Carl Zeiss Meditec Cirrus HD OCT 5000, Optovue RTV...

Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements

Recently a prototype of a combination of an anterior segment OCT (VISANTE; Carl Zeiss Meditec AG) and an operating microscope (OPMI 200; Carl Zeiss Meditec AG) was introduced that allows m...

Use of the Visumax™ Femtosecond Laser

The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or eli...

Companies [47 Associated Companies listed on BioPortfolio]

Carl Zeiss Meditec, Inc.

Carl Zeiss Meditec AG (ISIN: DE0005313704) is one of the world’s leading medical technology companies. The company supplies innovative technologies and application-oriented s...

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on TecDax of the German stock exchange, is one of the world’s leading medical technology companies. The company su...

Carl Zeiss Canada Ltd.

Carl Zeiss Canada Ltd was founded in 1963 with the scientific division selling and servicing laboratory and surgical microscopes and related products. In 1979 the optical division was added to supply ...

Carl Zeiss Vision

Carl Zeiss Vision (www.vision.zeiss.com) is a global leader in precision optics. With a full line of advanced customized lenses, advanced performance coatings, i.Scription® by ...

Carl Zeiss SMT

The Carl Zeiss Group is a leading group of companies operating worldwide in the optical and opto-electronic industries that generates revenues totaling around EUR 2.1 billion (200...

More Information about "Carl Zeiss Meditec AG" on BioPortfolio

We have published hundreds of Carl Zeiss Meditec AG news stories on BioPortfolio along with dozens of Carl Zeiss Meditec AG Clinical Trials and PubMed Articles about Carl Zeiss Meditec AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Carl Zeiss Meditec AG Companies in our database. You can also find out about relevant Carl Zeiss Meditec AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record